Risk factor
Strong & resilient to price shocks
Profitability factor
Very strong margins and returns
About
Astra Industrial Group Company functions as a diversified holding entity, conducting its operations globally through a network of subsidiaries. Its extensive international reach encompasses the Kingdom of Saudi Arabia, various parts of Africa, the United States, Asia, and Europe. The company's broad portfolio of activities includes: Pharmaceuticals: Engaging in the research, production, marketing, and distribution of both branded generic and licensed medicinal products. These address critical therapeutic areas, including central nervous system conditions, cardiovascular health, infectious diseases, respiratory illnesses, and musculoskeletal system disorders. Specialty Chemicals: Manufacturing key ingredients such as masterbatches, dust-free additives, customized thermoplastic compounds, and a variety of liquid and paste colorants, primarily serving the polymer processing, manufacturing, and converting sectors. Agriculture: Producing, importing, and distributing a wide array of agrochemicals, fertilizers, pesticides for public health and veterinary use, seeds, and other essential agricultural supplies. Power and Steel: Producing pre-engineered steel buildings, various steel structures, and fundamental steel products like billets and rebars, predominantly for the construction industry. The company also conducts exploration for ores and minerals as part of its mining operations. Industrial Ventures: Actively involved in the development, operation, management, and investment in industrial plants, alongside undertaking metal-based construction for buildings and structural frameworks. Astra Industrial Group Company was founded in 1988 and is headquartered in Riyadh, Saudi Arabia.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV
Target Price
The average target price of 1212.SR is 124 and suggests 5% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de